Medical Plastics Market

Executive Summary

Medical Plastics Market was valued at US $923.53 million in 2021 and is projected to grow at 8.52% CAGR over the forecast period to reach US $1,508.66 million by 2027. Medical Plastics Market represented US $139.37 million opportunity over 2019-2021 and estimated to create US $585.13 million opportunity in 2027 over 2021.

Medical Plastics from Consainsights analyses the Medical Plastics Market in the Life Sciences industry over the forecast period to 2027.

Medical Plastics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Plastics segmentation includes Type, Application, Region and Geography.

Based on the Type, the Medical Plastics analysis covers Standard Plastics, Engineering Plastics, High Performance Plastic (HPP), Silicone, Others.

In Type segment, Standard Plastics segment has highest cagr growth of 7.54%.

Based on the Application, the Medical Plastics analysis covers Medical Disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, Others.

In Application segment, Medical Disposables segment has highest cagr growth of 7.54%.

Based on the Region, the Medical Plastics analysis covers North America, Europe, APAC, Middle East & Africa, South America.

In Region segment, North America segment has highest cagr growth of 7.54%.

Based on the region, the Medical Plastics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include SABIC, BASF, Celanese Corporation, Evonik, Solvay, Arkema, Covestro, Ensinger, Lubrizol, Trinseo, Other Companies and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Standard Plastics segment has the highest revenue of US $392.98 million and is expected to grow at CAGR of 7.54% by 2027 Standard Plastics segment has highest cagr growth of 7.54%.

Standard Plastics

Standard Plastics segment was valued at US $333.68 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $641.97 million by 2027. Standard Plastics segment represented US $59.31 million opportunity over 2019-2021 and estimated to create US $248.98 million opportunity in 2027 over 2021.

Engineering Plastics

Engineering Plastics segment was valued at US $245.21 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $471.75 million by 2027. Engineering Plastics segment represented US $43.58 million opportunity over 2019-2021 and estimated to create US $182.97 million opportunity in 2027 over 2021.

High Performance Plastic (HPP)

High Performance Plastic (HPP) segment was valued at US $122.06 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $234.84 million by 2027. High Performance Plastic (HPP) segment represented US $21.69 million opportunity over 2019-2021 and estimated to create US $91.08 million opportunity in 2027 over 2021.

Silicone

Silicone segment was valued at US $82.79 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $159.29 million by 2027. Silicone segment represented US $14.71 million opportunity over 2019-2021 and estimated to create US $61.78 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.42 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $0.81 million by 2027. Others segment represented US $0.08 million opportunity over 2019-2021 and estimated to create US $0.32 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Medical Disposables segment has the highest revenue of US $429.69 million and is expected to grow at CAGR of 7.54% by 2027 Medical Disposables segment has highest cagr growth of 7.54%.

Medical Disposables

Medical Disposables segment was valued at US $364.84 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $701.93 million by 2027. Medical Disposables segment represented US $64.84 million opportunity over 2019-2021 and estimated to create US $272.24 million opportunity in 2027 over 2021.

Prosthetics

Prosthetics segment was valued at US $236.79 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $455.57 million by 2027. Prosthetics segment represented US $42.09 million opportunity over 2019-2021 and estimated to create US $176.69 million opportunity in 2027 over 2021.

Medical Instruments & Tools

Medical Instruments & Tools segment was valued at US $85.06 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $163.65 million by 2027. Medical Instruments & Tools segment represented US $15.12 million opportunity over 2019-2021 and estimated to create US $63.47 million opportunity in 2027 over 2021.

Drug Delivery

Drug Delivery segment was valued at US $67.73 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $130.30 million by 2027. Drug Delivery segment represented US $12.04 million opportunity over 2019-2021 and estimated to create US $50.54 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $29.74 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $57.22 million by 2027. Others segment represented US $5.29 million opportunity over 2019-2021 and estimated to create US $22.19 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $437.39 million and is expected to grow at CAGR of 7.54% by 2027 North America segment has highest cagr growth of 7.54%.

North America

North America segment was valued at US $371.39 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $714.51 million by 2027. North America segment represented US $66.01 million opportunity over 2019-2021 and estimated to create US $277.12 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $214.68 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $413.03 million by 2027. Europe segment represented US $38.16 million opportunity over 2019-2021 and estimated to create US $160.19 million opportunity in 2027 over 2021.

APAC

APAC segment was valued at US $106.78 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $205.44 million by 2027. APAC segment represented US $18.98 million opportunity over 2019-2021 and estimated to create US $79.68 million opportunity in 2027 over 2021.

Middle East & Africa

Middle East & Africa segment was valued at US $53.07 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $102.10 million by 2027. Middle East & Africa segment represented US $9.43 million opportunity over 2019-2021 and estimated to create US $39.60 million opportunity in 2027 over 2021.

South America

South America segment was valued at US $38.25 million in 2019 and is projected to grow at 7.54% CAGR over the forecast period to reach US $73.58 million by 2027. South America segment represented US $6.80 million opportunity over 2019-2021 and estimated to create US $28.54 million opportunity in 2027 over 2021.